Gene · 9401
Papers1,646
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,646
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients. | Int J Mol Sci | 2022 | 36555431 | PubTator, text mining | PubMed |
| A Systems Biology and LASSO-Based Approach to Decipher the Transcriptome-Interactome Signature for Predicting Non-Small Cell Lung Cancer. | Biology (Basel) | 2022 | 36552262 | PubTator, text mining | PubMed |
| Epidemiological, Clinical, and Genomic Profile in Head and Neck Cancer Patients and Their Families. | Biomedicines | 2022 | 36552033 | PubTator, text mining | PubMed |
| Cancer and Radiosensitivity Syndromes: Is Impaired Nuclear ATM Kinase Activity the Primum Movens? | Cancers (Basel) | 2022 | 36551628 | PubTator, text mining | PubMed |
| Deciphering a mitochondria-related signature to supervise prognosis and immunotherapy in hepatocellular carcinoma. | Front Immunol | 2022 | 36544763 | PubTator, text mining | PubMed |
| Novel THPO variant in hereditary thrombocytopenia: A potential candidate variant for predisposition to myeloid neoplasm. | PLoS One | 2022 | 36534659 | PubTator, text mining | PubMed |
| Complex molecular profile of DNA repair genes in epithelial ovarian carcinoma patients with different sensitivity to platinum-based therapy. | Front Oncol | 2022 | 36531044 | PubTator, text mining | PubMed |
| Towards the Search for Potential Biomarkers in Osteosarcoma: State-of-the-Art and Translational Expectations. | Int J Mol Sci | 2022 | 36499267 | PubTator, text mining | PubMed |
| Discovery of a Novel Bloom's Syndrome Protein (BLM) Inhibitor Suppressing Growth and Metastasis of Prostate Cancer. | Int J Mol Sci | 2022 | 36499126 | PubTator, text mining | PubMed |
| Splicing-Disrupting Mutations in Inherited Predisposition to Solid Pediatric Cancer. | Cancers (Basel) | 2022 | 36497448 | PubTator, text mining | PubMed |
| Identification of Altered Primary Immunodeficiency-Associated Genes and Their Implications in Pediatric Cancers. | Cancers (Basel) | 2022 | 36497424 | PubTator, text mining | PubMed |
| UBE2O ubiquitinates PTRF/CAVIN1 and inhibits the secretion of exosome-related PTRF/CAVIN1. | Cell Commun Signal | 2022 | 36443833 | PubTator, text mining | PubMed |
| Genetic mutation and tumor microbiota determine heterogenicity of tumor immune signature: Evidence from gastric and colorectal synchronous cancers. | Front Immunol | 2022 | 36420271 | PubTator, text mining | PubMed |
| Multisuture and Syndromic Craniosynostoses: Simplifying the Complex. | J Pediatr Neurosci | 2022 | 36388010 | PubTator, text mining | PubMed |
| Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma. | Biomark Res | 2022 | 36376989 | PubTator, text mining | PubMed |
| Systematic proximal mapping of the classical RAD51 paralogs unravel functionally and clinically relevant interactors for genome stability. | PLoS Genet | 2022 | 36374936 | PubTator, text mining | PubMed |
| Intersection of the Orphan G Protein-Coupled Receptor, GPR19, with the Aging Process. | Int J Mol Sci | 2022 | 36362387 | PubTator, text mining | PubMed |
| Prenatal Genetic Testing in the Era of Next Generation Sequencing: A One-Center Canadian Experience. | Genes (Basel) | 2022 | 36360262 | PubTator, text mining | PubMed |
| Current Status and Prospects of Targeted Therapy for Osteosarcoma. | Cells | 2022 | 36359903 | PubTator, text mining | PubMed |
| DNA repair-related genes and adipogenesis: Lessons from congenital lipodystrophies. | Genet Mol Biol | 2022 | 36354755 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9401/papers?page=14